If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekmar Group Regulatory News (TGP)

Share Price Information for Tekmar Group (TGP)

Share Price is delayed by 15 minutes
Get Live Data
14.50    0.00 (0.00%)
Bid:
14.00
Ask:
15.00
Spread: 1.00 (7.143%)
Market Cap: £20.27m
TGP Live PriceLast checked at - London Stock Exchange

Intraday Tekmar Group Share Chart

Bank Facility Extension & Strategic Review Update

10 Oct 2022 07:00

RNS Number : 2386C
Tekmar Group PLC
10 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE

THIS ANNOUNCEMENT CONTANS INSIDE INFORMATION FOR IMMEDIATE RELEASE

Tekmar Group plc

Extension of Banking Facility and Update on Strategic Review Process

The Board of Tekmar Group plc ("Tekmar" or the "Company") is pleased to announce it has agreed with Barclays Bank PLC ("Barclays") a 12-month extension of its committed £3.0m CBILs term loan facility. This extends the maturity date to 31 October 2023.

Gross cash at 30 September 2022 was £8.5m compared to £5.1m at 31 March 2022. After a drawdown of banking facilities of £7.0m, net cash was £1.5m, an improvement of over £2.0m since 31 March 2022, demonstrating strong cash collection over the last 6 months.

Derek Bulmer, CFO, commented, "We are pleased to have extended the £3m CBILs facility by a further 12 months and thank Barclays for their ongoing support and look forward to building on our strong relationship going forward. We remain focused on improving the Group's cash position and it is encouraging to see the hard work of the team reflected in the Company being cash generative in the last six months."

Update on Strategic Review and Formal Sales Process

On 13 June 2022, the Company announced that the Board had commenced a strategic review to seek a strategic partner to support its opportunities for growth and provide additional balance sheet strength. These options included, but were not limited to, a sale of the Company conducted under the framework of a "formal sale process" in accordance with the Takeover Code.

Having received indications of interest, the Company is exploring several options with interested parties. There can be no certainty that an offer will be made, nor as to the terms on which any offer will be made. Further updates will be made when appropriate.

Enquiries

Tekmar Group plc

Alasdair MacDonald, CEO +44 (0)1325 349 050

Derek Bulmer, CFO

 

Bamburgh Capital Ltd (Rule 3 Adviser and Joint Financial Adviser)

Murdo Montgomery +44 (0)131 376 0901

Richard Evans +44 (0)161 521 0286

Alex Clarkson +44 (0)161 240 7550

(email addresses: firstname@bamburghcapital.com)

 

Singer Capital Markets (Nominated Adviser, Joint Financial Adviser and Broker)

Rick Thompson +44 (0)20 7496 3000

Rachel Hayes

 

Additional information

The person responsible for arranging the release of this announcement on behalf of the Company is Derek Bulmer, Chief Financial Officer.

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available (subject to certain restrictions relating to persons resident in restricted jurisdictions) at https://investors.tekmar.co.uk/investors/investor-centre/ by no later than 12 noon (London time) on the business day following the date of this announcement. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) no. 596/2014 (as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018). On the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Bamburgh Capital Ltd, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

Singer Capital Advisory LLP, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting exclusively for the Company and for no one else in connection with the subject matter of this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in connection with the subject matter of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEDLFBLBLEFBE
Date   Source Headline
18th Jun 20267:05 amRNSInvestor Presentation via Investor Meet Company
18th Jun 20267:00 amRNSUnaudited Interim Results
20th May 20261:42 pmRNSIssue of Equity and Total Voting Rights
7th May 20262:46 pmRNSIssue of Equity and Total Voting Rights
7th May 202612:40 pmRNSGrant of Share Options
7th May 202612:32 pmRNSGrant of Share Options
27th Apr 20263:20 pmRNSHolding(s) in Company
23rd Apr 20269:38 amRNSHolding(s) in Company
31st Mar 20262:02 pmRNSResult of AGM
31st Mar 20267:00 amRNS£2m Contract Awards on Japanese Offshore Project
9th Mar 20267:17 amRNSNotice of AGM & Publication of Annual Report
9th Mar 20267:00 amRNSFinal Results
27th Feb 20264:09 pmRNSProperty Disposal
13th Feb 202610:24 amRNS£4m Contract for European Offshore Wind Project
8th Jan 202610:28 amRNSContract Award for Logistics Port Development
18th Dec 20257:00 amRNSSecond €8m Offshore Wind Contract Award
12th Dec 20253:41 pmRNSIssue of Equity, PDMR Dealings and TVR
4th Dec 20257:00 amRNS€8m Contract, Trading Update and Investor Meeting
27th Nov 20254:55 pmRNSHolding(s) in Company
24th Nov 20253:03 pmRNSAIM Rule 17 and Schedule 2(g) Update
17th Nov 20257:00 amRNSContract in the Middle East
23rd Oct 20257:00 amRNSExercise of Options
8th Oct 202512:52 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSFramework Agreement with Jan De Nul
1st Oct 20257:00 amRNSContract Award
24th Sep 20254:46 pmRNSHolding(s) in Company
15th Sep 20255:09 pmRNSHolding(s) in Company
10th Sep 20257:00 amRNSUS$10m Contract Award
4th Sep 20252:54 pmRNSHolding(s) in Company
2nd Sep 20257:00 amRNSTrading Update
27th Aug 20257:01 amRNSReplacement: Issue of Equity and TVR
27th Aug 20257:00 amRNSResolution of Legacy Defect Notifications
26th Aug 20253:51 pmRNSIssue of Equity and Total Voting Rights
22nd Aug 202512:50 pmRNSAppointment of CFO
19th Aug 20254:06 pmRNSAIM Rule 17 and Schedule 2(g) Update
18th Aug 20257:00 amRNSNew Contract Awards
13th Aug 20257:00 amRNSDirectorate Change
9th Jul 20257:00 amRNSContract Award for Middle East Project
26th Jun 20257:00 amRNSUnaudited Interim Results
12th May 20257:00 amRNSContract Win
9th May 20251:50 pmRNSReceipt of deferred consideration
4th Apr 20256:28 pmRNSHolding(s) in Company
27th Mar 202510:20 amRNSResult of AGM
26th Mar 202511:48 amRNSGrant of Conditional Share Options
24th Mar 20253:15 pmRNSLaunch of SAYE Scheme
20th Mar 20257:00 amRNSCommercial Settlement
7th Mar 20252:11 pmRNSIssue of Equity and Total Voting Rights
6th Mar 202512:22 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
4th Mar 20257:05 amRNSNotice of AGM & Investor Site Visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.